In line with the overexpression results, knocking down Roquin2 increased the mRNA levels of angiogenic genes, including ENG, EDN1, VEGFB, and PDGFC in breast cancer cells (Fig. 6B). This evidence concerns the gene PDGFC and breast carcinoma.